期刊文献+

压力负荷性大鼠肥厚心肌过氧化物酶体增殖剂活化受体α(PPARα)和肉碱棕榈酰转移酶(MCPT-I)mRNA的表达变化 被引量:8

Expression of PPAR α and M-CPT-ImRNA in Cardiac Hypertrophy
下载PDF
导出
摘要 目的 了解压力负荷性肥厚心肌PPARα和M CPT ImRNA的表达变化 ,探讨PPARα调控心肌线粒体脂肪酸摄取及维持能量和脂质平衡的作用。方法 观察大鼠腹主动脉缩窄术后 2、4、8、16周血流动力学参数、心室重塑指标、血清和心肌游离脂肪酸的含量及PPARα和M CPT ImRNA的表达变化。结果 随着肥厚程度的增加 ,压力负荷性大鼠血清和心肌游离脂肪酸蓄积增加 ,心肌PPARα和M CPT ImRNA的表达逐渐下调 ,而且与脂肪酸的利用下调相一致。结论 病理性肥厚心肌能量代谢底物发生改变 ,脂肪酸氧化不占主导地位 ;PPARα在转录水平上失活 ,对心肌线粒体脂肪酸摄取起重要的调控作用 ; Objective To study the expression of PPAR α and M CPT I mRNA in cardiac hypertrophy and the regulation effect of PPAR α on mitochondrial fatty acid uptake. Methods Using a model of cardiac hypertrophy induced by coarctation of abdominal aorta(CAA) in male Wistar rats, hemodynamics, ventricular remodeling parameters, free fatty acid in blood serum and cardiac myocyte and expression of PPAR α and M CPT I mRNA were investigated 2, 4, 8, 16 weeks after operation and sham operation. Results Cardiac PPAR α and M CPT I gene expression were decreased, meanwhile the accumulation of free fatty acid and a reduction in uptake of fatty acid in myocardium were manifested in the development of cardiac hypertrophy. Conclusion The metabolic substrate in hypertrophic myocardium underwent substantial changes. Fatty acid oxidation appears not to be a major substrate of energy metabolism in cardiac hypertrophy. PPAR α is deactivated at transcriptional level and plays a key role on mitochondrial import of fatty acids in myocardial, leading to diminish in myocardial lipid and energy homeostasis.
出处 《高血压杂志》 CSCD 2003年第1期65-68,共4页 Chinese Journal of Hypertension
关键词 压力负荷性大鼠 肥厚心肌 过氧化物酶体增殖剂活化受体 心肌线粒体脂肪酸 cardiac hypertrophy peroxisome proliferator activated receptors α(PPAR α) muscle carnitine palmitoyltransferase I (M CPT I )
  • 相关文献

同被引文献67

  • 1朱全,浦钧宗.大鼠游泳训练在运动实验中的应用方法[J].中国运动医学杂志,1996,15(2):125-129. 被引量:116
  • 2刘世明,丁月霞,钟赟,刘启才,李冰.PPARs激动剂上调内皮细胞表达eNOS并增加NO生成[J].中国病理生理杂志,2006,22(5):911-914. 被引量:4
  • 3孙雅逊,胡申江,张志杰,康兰,赵晓燕,郑霞.阿托伐他汀改善自发性高血压大鼠的心肌脂质代谢和抑制心肌肥厚[J].中华高血压杂志,2006,14(8):632-635. 被引量:18
  • 4[2]LehInan JJ, Kelly DP. Gene rgulatory mechanisms goveming energy metabolism dumg cardiac hypertrophic growth. Heart Fail Rev.2002,7(2):175 ~ 185.
  • 5[5]Rossi MA, Ramos SG, Prado CM. Chronic inhibition of nitric oxide synthase induces hyper-tension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy.J Hypertens.2003,21 (5) :993 ~ 1001.
  • 6[7]Marban E, Koretsune Y. Cell calcium, oncogenes, and hypertrophy. Hypertension. 1990,15 (6 Pt 1 ): 652 ~ 658.
  • 7[8]Irukayama-Tomobe Y, Miyauchi T, Sakai S, et al. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferatoractivated receptor-alpha panly via blockade of c-Jun NH2-terminal kinase pathway. Circulation.2004,109(7) :904 ~ 910.
  • 8[9]Liang F, Wang F, Zhang S, et al. Peroxisome proliferator activated receptor (PPAR) alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes. Endocrinology. 2003,144(9) :4187 ~ 4194.
  • 9[10]Mezei O, Banz WJ, Steger RW, et al. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr. 2003,133:1238~ 1243.
  • 10[11]Babiker FA,De Wndt LJ,Van EickelsM,et al.17beta-estradiol amagonizes caxdiomyocyte hypertrophy by auocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine mo nopho sphate-dependeni prote in kinase pathway. Circulation.2004,109(2) :269 ~ 276.

引证文献8

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部